Institut de Formation Continue, Sciences et Médecine financials
A multi-period view of the public annual-account figures reported for Institut de Formation Continue, Sciences et Médecine, with comparable measures and links to available source documents.
Company overviewRegistry number
0860682978
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 27, 2026
Financial evidence
Latest movements for Institut de Formation Continue, Sciences et Médecine
2025 versus 2024
- Operating line
- €482,991
- EBITDA
- €36,904
- Total assets
- €648,914
- Equity
- €468,420
-3.6%
-39%
+8%
+8.7%
EBITDA margin +7.6% · Equity ratio +72.2%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €482,991 | €36,904 | €648,914 | €468,420 | - |
| 202431 Dec 2024 | €500,942 | €60,474 | €600,749 | €430,812 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.